TY  - JOUR
T1  - USe of ppis are not associated with mortality in institutionalized older people—reply
AU  - Bell J, Strandberg TE, Pitkälä KH
Y1  - 2011/05/09
N1  - 10.1001/archinternmed.2011.165
JO  - Archives of Internal Medicine
SP  - 866
EP  - 867
VL  - 171
IS  - 9
N2  - 
Twelve-month mortality among the residents of intermediate-level aged care facilities studied by Wilson and colleagues was 10.3% compared with 28.2% and 24.9% in our 2 cohorts.1 In addition to possible differences in organization of care, the lower mortality may attributed to the fact that residents were only eligible for inclusion in their falls prevention study if facility staff judged that they were likely to survive for 12 months.2 It is possible, therefore, that frail residents most susceptible to adverse drug events associated with PPIs were not included in the study.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2011.165
UR  - http://dx.doi.org/10.1001/archinternmed.2011.165
ER  -